Pablo Lapuerta
Pablo Lapuerta publishes mostly in Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Epidemiology, on topics such as Neuroendocrine Tumor Research Advances, Diabetes Treatment and Management and Blood Pressure and Hypertension Studies.
- World rank
- #743,836 of 7,710,434 ranked researchers
- Rank in United States
- #250,002 of 1,627,098
- Works
- 201
- Citations
- 11k
- Citations per work
- 56.2
What does Pablo Lapuerta research?
Pablo Lapuerta's work is mostly in Medicine (62%), Economics, Econometrics and Finance (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences12562.2%
- Medicine12562.2%
- Everything else6934.4%
- Social Sciences73.4%
- 1Endocrinology, Diabetes and Metabolism22% of their works
- 2Cardiology and Cardiovascular Medicine12% of their works
- 3Epidemiology12% of their works
- 4Surgery11% of their works
- 5Neurology5% of their works
- 6Economics and Econometrics3% of their works
Research topics
Which keywords describe Pablo Lapuerta's research?
The keywords of their largest research topics: Genetic Mutations, Clinical Guidelines, Glycemic Control, Insulin Therapy, Cardiovascular Disease, Neuroendocrine Tumors, Pancreatic Neuroendocrine Tumors and Diabetes Mellitus.
- Primary Aldosteronism
- ß-Cell Dysfunction
- Hypoglycemia
- Pituitary Adenomas
- Cushing's Syndrome
- Blood Pressure
- Type 2 Diabetes
- Hypertension
- Diabetes Mellitus
- Neuroendocrine Tumors
- Insulin Therapy
- Clinical Guidelines
- Genetic Mutations
- Glycemic Control
- Cardiovascular Disease
- Pancreatic Neuroendocrine Tumors
- Cardiovascular Events
- Cardiovascular Outcomes
- Antihypertensive Drugs
- ALK
- Neuroblastoma
- Diabetes
- Pancreatic Islets
- Aldosterone
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Genetic Mutations772 topics
- Clinical Guidelines722 topics
- Glycemic Control662 topics
- Insulin Therapy662 topics
- Cardiovascular Disease562 topics
- Neuroendocrine Tumors511 topic
- Pancreatic Neuroendocrine Tumors511 topic
- Diabetes Mellitus472 topics
- Cardiovascular Events432 topics
- Hypertension432 topics
- Cardiovascular Outcomes411 topic
- Type 2 Diabetes411 topic
- Antihypertensive Drugs311 topic
- Blood Pressure311 topic
- ALK261 topic
- Cushing's Syndrome261 topic
- Neuroblastoma261 topic
- Pituitary Adenomas261 topic
- Diabetes251 topic
- Hypoglycemia251 topic
- Pancreatic Islets161 topic
- ß-Cell Dysfunction161 topic
- Aldosterone121 topic
- Primary Aldosteronism121 topic
Where does Pablo Lapuerta work?
Pablo Lapuerta's main affiliation in the publication record is Lexicon Pharmaceuticals (United States), United States.
How many publications and citations does Pablo Lapuerta have?
OpenAlex counts 201 works and 11,289 citations for Pablo Lapuerta, an h-index of 45, ranking #743,836 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Pablo Lapuerta. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.